SlideShare une entreprise Scribd logo
1  sur  4
Télécharger pour lire hors ligne
Controversy - The Cause of
Alzheimer's
By Michael Mullan
Controversy - The Cause of Alzheimer's
By Dr. Michael Mullan
A recent paper by a huge international collaborative group of
researchers has re-fired the controversy over what really
causes Alzheimer's disease. For many years, researchers have
argued that the amyloid protein is the central cause of the
disease. However, in commenting on the recent finding,
Professor Julie Williams said, "There is something in the
immune response which is causing Alzheimer's disease…."
according to a BBC report. Dr. Williams' use of the term
"causing" is strong language and contrasts sharply with the
beliefs of other scientists who promote the "amyloid cascade
theory." According to that theory, amyloid is the cause of
Alzheimer's disease and brings about the demise of neurons
by toxic and inflammatory processes as it accumulates in the
brain.
In the new findings of 11 more genes associated with
Alzheimer's disease (bringing the total to 21), the immune
system seems to be implicated. Several other studies have
previously implicated the immune system. For instance, a
1999 paper from our own group, published in Science,
implicated the molecule CD40 which plays a central role in
the immune system. Knocking out CD40 dramatically reduced
the amount of amyloid accumulation in transgenic mouse
models of Alzheimer's expressing human mutations which
trigger early onset disease.
The new gene findings also point to a process called
endocytosis which is the internalization of the cell membrane
typically after a receptor has been triggered. Interestingly, we
have also shown that CD40 triggers endocytosis and, in so
doing, it increases the amount of amyloid produced by brain
cells. Although the new genetic findings do not give any clear
indication of why the immune system may be important, the
implication of immune proteins will generate many new
theories. Previously, many researchers have noted the role of
inflammation and innate immunity in Alzheimer's disease
and it may be that these new genetic findings will assist in
our understanding of the role of the immune system.
However, the sheer size of the study, which according to the
BBC website required over 17,000 patients and 37,000
healthy controls, suggests that the effect of some of these
genes may be very small. This then naturally gives rise to the
question of whether the findings are generalizable to all
Alzheimer patients. In addition, the key question of whether
any treatments will emerge from these genetic findings is
another area hotly debated.

Although the genetic role of genes like APP has been known
for over 20 years, no therapies have yet been approved which
are directed towards the amyloid protein. Similarly, although
the APOE gene was implicated in Alzheimer's disease 20
years ago, no treatments have emerged as a consequence.
Scientists argue that if a gene such as APOE which has such a
large influence on the population's risk for Alzheimer's has not
resulted in a new treatment, why would the discovery of genes
of much smaller effect be likely to result in new treatments?
However, Professor Williams' comment may suggest that one
of the values of such studies is to move the field away from
focusing so intently on amyloid towards other potential
therapeutic targets.
Although the hunt for amyloid therapies has been incessant
over the last 20 years, major vaccine studies have failed or
shown minimal effect and consequently, researchers are trying
to advance anti-amyloid treatments at an early age. Others
vehemently oppose this approach, suggesting that amyloid is
just the wrong target and that other molecular targets should
be sought. Perhaps this new study will switch the focus away
from amyloid to the immune and other systems?
The origins of Alzheimer's disease have always been hotly
debated with researchers taking very strong opinions on the
cause of the disease. This intellectual battle seems set to
continue with new findings such as those revealed by the
present study.

Contenu connexe

Tendances

AdVax - Oral Systemic Biology
AdVax - Oral Systemic BiologyAdVax - Oral Systemic Biology
AdVax - Oral Systemic Biologydrdansindelar
 
Relationship between aging immunoglobulin g, and chronic rhinosinusitis
Relationship between aging immunoglobulin g, and chronic rhinosinusitisRelationship between aging immunoglobulin g, and chronic rhinosinusitis
Relationship between aging immunoglobulin g, and chronic rhinosinusitisFrank Reynold
 
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...Asmallergie
 
Fact Sheet: Inhaling the Less Harmful Alternative to Smoking
Fact Sheet: Inhaling the Less Harmful Alternative to SmokingFact Sheet: Inhaling the Less Harmful Alternative to Smoking
Fact Sheet: Inhaling the Less Harmful Alternative to SmokingEric_Berry
 
NEW PROTEIN STRUCTURE COULD HELP TREAT ALZHEIMER´S, RELATED DISEASES AND WHEN...
NEW PROTEIN STRUCTURE COULD HELP TREAT ALZHEIMER´S, RELATED DISEASES AND WHEN...NEW PROTEIN STRUCTURE COULD HELP TREAT ALZHEIMER´S, RELATED DISEASES AND WHEN...
NEW PROTEIN STRUCTURE COULD HELP TREAT ALZHEIMER´S, RELATED DISEASES AND WHEN...manuelavalenciabo
 
Autism Spectrum Disorders And Thimerosal In Vaccines
Autism Spectrum Disorders And Thimerosal In VaccinesAutism Spectrum Disorders And Thimerosal In Vaccines
Autism Spectrum Disorders And Thimerosal In Vaccinesadroits
 
William Faloon on Age Reversal
William Faloon on Age ReversalWilliam Faloon on Age Reversal
William Faloon on Age ReversalAlex Vidal
 
Central dogma of genetic information
Central dogma of genetic informationCentral dogma of genetic information
Central dogma of genetic informationCarolina Salazar
 
Tinkering, Tweaking, and Tuning
Tinkering, Tweaking, and TuningTinkering, Tweaking, and Tuning
Tinkering, Tweaking, and TuningDrBonnie360
 
Amygdala neurons reduced in adults with autism
Amygdala neurons reduced in adults with autismAmygdala neurons reduced in adults with autism
Amygdala neurons reduced in adults with autismCurtis Cripe
 

Tendances (16)

AdVax - Oral Systemic Biology
AdVax - Oral Systemic BiologyAdVax - Oral Systemic Biology
AdVax - Oral Systemic Biology
 
Relationship between aging immunoglobulin g, and chronic rhinosinusitis
Relationship between aging immunoglobulin g, and chronic rhinosinusitisRelationship between aging immunoglobulin g, and chronic rhinosinusitis
Relationship between aging immunoglobulin g, and chronic rhinosinusitis
 
Alzheimer's
Alzheimer'sAlzheimer's
Alzheimer's
 
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
 
Fact Sheet: Inhaling the Less Harmful Alternative to Smoking
Fact Sheet: Inhaling the Less Harmful Alternative to SmokingFact Sheet: Inhaling the Less Harmful Alternative to Smoking
Fact Sheet: Inhaling the Less Harmful Alternative to Smoking
 
NEW PROTEIN STRUCTURE COULD HELP TREAT ALZHEIMER´S, RELATED DISEASES AND WHEN...
NEW PROTEIN STRUCTURE COULD HELP TREAT ALZHEIMER´S, RELATED DISEASES AND WHEN...NEW PROTEIN STRUCTURE COULD HELP TREAT ALZHEIMER´S, RELATED DISEASES AND WHEN...
NEW PROTEIN STRUCTURE COULD HELP TREAT ALZHEIMER´S, RELATED DISEASES AND WHEN...
 
Autism Spectrum Disorders And Thimerosal In Vaccines
Autism Spectrum Disorders And Thimerosal In VaccinesAutism Spectrum Disorders And Thimerosal In Vaccines
Autism Spectrum Disorders And Thimerosal In Vaccines
 
William Faloon on Age Reversal
William Faloon on Age ReversalWilliam Faloon on Age Reversal
William Faloon on Age Reversal
 
SMART Team Research
SMART Team ResearchSMART Team Research
SMART Team Research
 
Science Of Vaccine Damage
Science Of Vaccine DamageScience Of Vaccine Damage
Science Of Vaccine Damage
 
Central dogma of genetic information
Central dogma of genetic informationCentral dogma of genetic information
Central dogma of genetic information
 
James patrick allison
James patrick allisonJames patrick allison
James patrick allison
 
Tinkering, Tweaking, and Tuning
Tinkering, Tweaking, and TuningTinkering, Tweaking, and Tuning
Tinkering, Tweaking, and Tuning
 
Epigenetics
EpigeneticsEpigenetics
Epigenetics
 
Amygdala neurons reduced in adults with autism
Amygdala neurons reduced in adults with autismAmygdala neurons reduced in adults with autism
Amygdala neurons reduced in adults with autism
 
The Central dogma
The Central dogmaThe Central dogma
The Central dogma
 

En vedette

Tika yusuf public speaking coaching cliniques
Tika yusuf   public speaking coaching cliniquesTika yusuf   public speaking coaching cliniques
Tika yusuf public speaking coaching cliniquesluqmanhebat
 
Flipbook film260 chrissong
Flipbook film260 chrissongFlipbook film260 chrissong
Flipbook film260 chrissonggkfn4278
 
Menentukan Pilihan Kuliah
Menentukan Pilihan KuliahMenentukan Pilihan Kuliah
Menentukan Pilihan Kuliahluqmanhebat
 
Expresiones regulares edward
Expresiones regulares edwardExpresiones regulares edward
Expresiones regulares edwardEdward Larez
 
Can You Minimize the Risk of Alzheimer’s?
Can You Minimize the Risk of Alzheimer’s?Can You Minimize the Risk of Alzheimer’s?
Can You Minimize the Risk of Alzheimer’s?Michael Mullan
 
Sistemas de informacion
Sistemas de informacionSistemas de informacion
Sistemas de informacionEdward Larez
 
Instrumen bm ayer keroh
Instrumen bm ayer kerohInstrumen bm ayer keroh
Instrumen bm ayer kerohLoga Sumugam
 
Microsoft, antivirus y wirar
Microsoft, antivirus y wirarMicrosoft, antivirus y wirar
Microsoft, antivirus y wirarMichelle Caudillo
 
Hassan presentation of corpus
Hassan presentation of corpusHassan presentation of corpus
Hassan presentation of corpusHassan Ammar
 
Mashup Awards 睡MEME打破
Mashup Awards 睡MEME打破Mashup Awards 睡MEME打破
Mashup Awards 睡MEME打破Junki Miura
 

En vedette (16)

Tika yusuf public speaking coaching cliniques
Tika yusuf   public speaking coaching cliniquesTika yusuf   public speaking coaching cliniques
Tika yusuf public speaking coaching cliniques
 
Flipbook film260 chrissong
Flipbook film260 chrissongFlipbook film260 chrissong
Flipbook film260 chrissong
 
For school
For schoolFor school
For school
 
Menentukan Pilihan Kuliah
Menentukan Pilihan KuliahMenentukan Pilihan Kuliah
Menentukan Pilihan Kuliah
 
Controladores
ControladoresControladores
Controladores
 
Netology design by_kerya
Netology design by_keryaNetology design by_kerya
Netology design by_kerya
 
Expresiones regulares edward
Expresiones regulares edwardExpresiones regulares edward
Expresiones regulares edward
 
Can You Minimize the Risk of Alzheimer’s?
Can You Minimize the Risk of Alzheimer’s?Can You Minimize the Risk of Alzheimer’s?
Can You Minimize the Risk of Alzheimer’s?
 
Sistemas de informacion
Sistemas de informacionSistemas de informacion
Sistemas de informacion
 
Instrumen bm ayer keroh
Instrumen bm ayer kerohInstrumen bm ayer keroh
Instrumen bm ayer keroh
 
Microsoft, antivirus y wirar
Microsoft, antivirus y wirarMicrosoft, antivirus y wirar
Microsoft, antivirus y wirar
 
Doc1
Doc1Doc1
Doc1
 
Styliostic ppt
Styliostic pptStyliostic ppt
Styliostic ppt
 
Hassan presentation of corpus
Hassan presentation of corpusHassan presentation of corpus
Hassan presentation of corpus
 
Discourse ppt
Discourse pptDiscourse ppt
Discourse ppt
 
Mashup Awards 睡MEME打破
Mashup Awards 睡MEME打破Mashup Awards 睡MEME打破
Mashup Awards 睡MEME打破
 

Similaire à Controversy - The Cause of Alzheimer's / By Michael Mullan

Altzheimer latest findings
Altzheimer latest findingsAltzheimer latest findings
Altzheimer latest findingsHeinz Rainer
 
ALZHEYMER'S DISEASE, ZIKA VIRUS AND PROTEINS
ALZHEYMER'S DISEASE, ZIKA VIRUS AND PROTEINS ALZHEYMER'S DISEASE, ZIKA VIRUS AND PROTEINS
ALZHEYMER'S DISEASE, ZIKA VIRUS AND PROTEINS Carlos Lopez Diaz
 
ASIA: Autoimmune/Inflammatory Syndrome Induced By Adjuvants
ASIA: Autoimmune/Inflammatory Syndrome Induced By AdjuvantsASIA: Autoimmune/Inflammatory Syndrome Induced By Adjuvants
ASIA: Autoimmune/Inflammatory Syndrome Induced By AdjuvantsJeffPrager1
 
Case Study Of Multiple Sclerosis (MS)
Case Study Of Multiple Sclerosis (MS)Case Study Of Multiple Sclerosis (MS)
Case Study Of Multiple Sclerosis (MS)Kristen Lee
 
Alzheimers Causes and Treatments
Alzheimers Causes and TreatmentsAlzheimers Causes and Treatments
Alzheimers Causes and Treatmentsscottizat
 
Covid 19-antibodies-pdf
Covid 19-antibodies-pdfCovid 19-antibodies-pdf
Covid 19-antibodies-pdfELIAS OMEGA
 
Symptoms And Symptoms Of Epilepsy
Symptoms And Symptoms Of EpilepsySymptoms And Symptoms Of Epilepsy
Symptoms And Symptoms Of EpilepsySheena Crouch
 
Luisetto m et al (2017) immune shock chronologic event in some brain patho...
Luisetto m et al  (2017) immune shock   chronologic event in some brain patho...Luisetto m et al  (2017) immune shock   chronologic event in some brain patho...
Luisetto m et al (2017) immune shock chronologic event in some brain patho...M. Luisetto Pharm.D.Spec. Pharmacology
 
Neurodevelopmental And Neurocognitive Disorders Essay
Neurodevelopmental And Neurocognitive Disorders EssayNeurodevelopmental And Neurocognitive Disorders Essay
Neurodevelopmental And Neurocognitive Disorders EssayPatricia Adams
 
Can vaccines cause autoimmune disorders
Can vaccines cause autoimmune disordersCan vaccines cause autoimmune disorders
Can vaccines cause autoimmune disorderskirti betai
 
Non-Communicable Diseases
Non-Communicable DiseasesNon-Communicable Diseases
Non-Communicable DiseasesJohn Bergman
 
A review on treatment of alzheimer disease
A review on treatment of alzheimer diseaseA review on treatment of alzheimer disease
A review on treatment of alzheimer diseasePriti Pal
 
Amyloid diseases- Is there light at the end of the tunnel_
Amyloid diseases- Is there light at the end of the tunnel_Amyloid diseases- Is there light at the end of the tunnel_
Amyloid diseases- Is there light at the end of the tunnel_Jonathon Burke
 
Vaccines: The Effects and Risks
Vaccines: The Effects and RisksVaccines: The Effects and Risks
Vaccines: The Effects and RisksEmily M Morgan
 

Similaire à Controversy - The Cause of Alzheimer's / By Michael Mullan (20)

Altzheimer latest findings
Altzheimer latest findingsAltzheimer latest findings
Altzheimer latest findings
 
Proteins
ProteinsProteins
Proteins
 
ALZHEYMER'S DISEASE, ZIKA VIRUS AND PROTEINS
ALZHEYMER'S DISEASE, ZIKA VIRUS AND PROTEINS ALZHEYMER'S DISEASE, ZIKA VIRUS AND PROTEINS
ALZHEYMER'S DISEASE, ZIKA VIRUS AND PROTEINS
 
ASIA: Autoimmune/Inflammatory Syndrome Induced By Adjuvants
ASIA: Autoimmune/Inflammatory Syndrome Induced By AdjuvantsASIA: Autoimmune/Inflammatory Syndrome Induced By Adjuvants
ASIA: Autoimmune/Inflammatory Syndrome Induced By Adjuvants
 
Case Study Of Multiple Sclerosis (MS)
Case Study Of Multiple Sclerosis (MS)Case Study Of Multiple Sclerosis (MS)
Case Study Of Multiple Sclerosis (MS)
 
Environment or Genetics?
Environment or Genetics?Environment or Genetics?
Environment or Genetics?
 
Alzheimers Causes and Treatments
Alzheimers Causes and TreatmentsAlzheimers Causes and Treatments
Alzheimers Causes and Treatments
 
Covid 19-antibodies-pdf
Covid 19-antibodies-pdfCovid 19-antibodies-pdf
Covid 19-antibodies-pdf
 
Symptoms And Symptoms Of Epilepsy
Symptoms And Symptoms Of EpilepsySymptoms And Symptoms Of Epilepsy
Symptoms And Symptoms Of Epilepsy
 
Luisetto m et al (2017) immune shock chronologic event in some brain patho...
Luisetto m et al  (2017) immune shock   chronologic event in some brain patho...Luisetto m et al  (2017) immune shock   chronologic event in some brain patho...
Luisetto m et al (2017) immune shock chronologic event in some brain patho...
 
Neurodevelopmental And Neurocognitive Disorders Essay
Neurodevelopmental And Neurocognitive Disorders EssayNeurodevelopmental And Neurocognitive Disorders Essay
Neurodevelopmental And Neurocognitive Disorders Essay
 
Can vaccines cause autoimmune disorders
Can vaccines cause autoimmune disordersCan vaccines cause autoimmune disorders
Can vaccines cause autoimmune disorders
 
Plegable biomol
Plegable biomolPlegable biomol
Plegable biomol
 
Non-Communicable Diseases
Non-Communicable DiseasesNon-Communicable Diseases
Non-Communicable Diseases
 
A review on treatment of alzheimer disease
A review on treatment of alzheimer diseaseA review on treatment of alzheimer disease
A review on treatment of alzheimer disease
 
Fuerza Contra Alzheimer November 2015
Fuerza Contra Alzheimer November 2015Fuerza Contra Alzheimer November 2015
Fuerza Contra Alzheimer November 2015
 
Harnessing The Power Of The Immune System
Harnessing The Power Of The Immune SystemHarnessing The Power Of The Immune System
Harnessing The Power Of The Immune System
 
Amyloid diseases- Is there light at the end of the tunnel_
Amyloid diseases- Is there light at the end of the tunnel_Amyloid diseases- Is there light at the end of the tunnel_
Amyloid diseases- Is there light at the end of the tunnel_
 
Systemic lupus
Systemic lupusSystemic lupus
Systemic lupus
 
Vaccines: The Effects and Risks
Vaccines: The Effects and RisksVaccines: The Effects and Risks
Vaccines: The Effects and Risks
 

Dernier

Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 

Dernier (20)

Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 

Controversy - The Cause of Alzheimer's / By Michael Mullan

  • 1. Controversy - The Cause of Alzheimer's By Michael Mullan
  • 2. Controversy - The Cause of Alzheimer's By Dr. Michael Mullan A recent paper by a huge international collaborative group of researchers has re-fired the controversy over what really causes Alzheimer's disease. For many years, researchers have argued that the amyloid protein is the central cause of the disease. However, in commenting on the recent finding, Professor Julie Williams said, "There is something in the immune response which is causing Alzheimer's disease…." according to a BBC report. Dr. Williams' use of the term "causing" is strong language and contrasts sharply with the beliefs of other scientists who promote the "amyloid cascade theory." According to that theory, amyloid is the cause of Alzheimer's disease and brings about the demise of neurons by toxic and inflammatory processes as it accumulates in the brain. In the new findings of 11 more genes associated with Alzheimer's disease (bringing the total to 21), the immune system seems to be implicated. Several other studies have previously implicated the immune system. For instance, a 1999 paper from our own group, published in Science, implicated the molecule CD40 which plays a central role in the immune system. Knocking out CD40 dramatically reduced the amount of amyloid accumulation in transgenic mouse models of Alzheimer's expressing human mutations which trigger early onset disease.
  • 3. The new gene findings also point to a process called endocytosis which is the internalization of the cell membrane typically after a receptor has been triggered. Interestingly, we have also shown that CD40 triggers endocytosis and, in so doing, it increases the amount of amyloid produced by brain cells. Although the new genetic findings do not give any clear indication of why the immune system may be important, the implication of immune proteins will generate many new theories. Previously, many researchers have noted the role of inflammation and innate immunity in Alzheimer's disease and it may be that these new genetic findings will assist in our understanding of the role of the immune system. However, the sheer size of the study, which according to the BBC website required over 17,000 patients and 37,000 healthy controls, suggests that the effect of some of these genes may be very small. This then naturally gives rise to the question of whether the findings are generalizable to all Alzheimer patients. In addition, the key question of whether any treatments will emerge from these genetic findings is another area hotly debated. Although the genetic role of genes like APP has been known for over 20 years, no therapies have yet been approved which are directed towards the amyloid protein. Similarly, although the APOE gene was implicated in Alzheimer's disease 20 years ago, no treatments have emerged as a consequence.
  • 4. Scientists argue that if a gene such as APOE which has such a large influence on the population's risk for Alzheimer's has not resulted in a new treatment, why would the discovery of genes of much smaller effect be likely to result in new treatments? However, Professor Williams' comment may suggest that one of the values of such studies is to move the field away from focusing so intently on amyloid towards other potential therapeutic targets. Although the hunt for amyloid therapies has been incessant over the last 20 years, major vaccine studies have failed or shown minimal effect and consequently, researchers are trying to advance anti-amyloid treatments at an early age. Others vehemently oppose this approach, suggesting that amyloid is just the wrong target and that other molecular targets should be sought. Perhaps this new study will switch the focus away from amyloid to the immune and other systems? The origins of Alzheimer's disease have always been hotly debated with researchers taking very strong opinions on the cause of the disease. This intellectual battle seems set to continue with new findings such as those revealed by the present study.